Atheroklefit, drops, 100 ml
€11.46 €9.55
Pharmacotherapeutic group
Hypolipidemic drug of plant origin
ATC code: C10AX
Pharmacological properties
Pharmacodynamics
p> Atheroklefit® is a liquid extract from the red clover grass collected during the flowering phase. The extract is obtained by double extraction of red clover grass with 40% ethanol.
According to preclinical studies, the liquid extract of red clover herb has moderate hypolipidemic effect: it helps to decrease the concentration of total cholesterol, concentration of low-density lipoproteins (LDL) and increase the concentration of high-density lipoproteins (HDL).
The mechanism of action of the liquid extract of red clover herb is associated with a redistribution of cholesterol from LDL to HDL, in which cholesterol is more quickly metabolized and eliminated from the body.
The liquid extract of the herb clover red also helps reduce the intensity of lipid peroxidation, resulting in reduced lipoprotein peroxidation and normalizes the permeability of the vascular wall.
Pharmacokinetics
There are no data available.
Indications
Hyperlipidemia type lla according to Frederickson, mild.
Pharmacological effect
Pharmacotherapeutic group
Hypolipidemic agent of plant origin
ATX code: C10AX
Pharmacological properties
Pharmacodynamics
Atheroclefit® is a liquid extract from the herb red clover, collected during the flowering phase. The extract was obtained by double extraction of red clover grass with 40% ethanol.
According to the results of preclinical studies, the liquid extract of red clover herb has a moderate lipid-lowering effect: it helps reduce the concentration of total cholesterol, the concentration of low-density lipoproteins (LDL) and increase the concentration of high-density lipoproteins (HDL).
The mechanism of action of the liquid extract of red clover herb is associated with the redistribution of cholesterol from LDL to HDL, in which cholesterol is more quickly metabolized and excreted from the body.
Liquid extract of the red clover herb also helps to reduce the intensity of lipid peroxidation, as a result of which the peroxide modification of lipoproteins decreases and the permeability of the vascular wall is normalized.
Pharmacokinetics
No data available.
Special instructions
Before you start using the drug, you should consult your doctor.
During therapy with Atheroklefit®, it is necessary to monitor the activity of “liver” transaminases, creatine phosphokinase, and control of kidney function.
For this purpose, while taking the drug Atheroclefit®, it is recommended to visit a doctor at least once a month in order to adjust therapy if necessary. The frequency and timing of visits are determined by the attending physician.
The ethanol content in the preparation is at least 35%. A single dose of the drug (1 teaspoon) contains 1.58 g of absolute ethyl alcohol, the maximum daily dose (3 teaspoons) contains 4.74 g of absolute ethyl alcohol.
Do not exceed the indicated daily dose.
Women of childbearing age should use reliable methods of contraception when using the drug.
Impact on the ability to drive vehicles and machinery
During treatment with Atheroclefit®, it is necessary to refrain from driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.
Active ingredient
Clover herb extract
Composition
To obtain 1000 ml of the drug use:
Active ingredient:
Clover grass – 500 g
Excipient:
Ethanol (ethyl alcohol) 40% is a sufficient amount to obtain 1000 ml of the drug.
Pregnancy
The drug is contraindicated for use during pregnancy and breastfeeding.
Contraindications
Hypersensitivity to the components of the drug; age under 18 years, traumatic brain injury, brain diseases, liver diseases, severe renal dysfunction, alcoholism (due to the presence of ethanol in the composition).
Use with caution in patients with mild to moderate renal impairment.
Persons with chronic diseases must consult a doctor before using the drug.
Side Effects
Orally: 1 teaspoon of the drug, previously diluted in 1/3 glass of water, 3 times a day 30 minutes before meals. The course of treatment is 3-6 months. A repeat course of treatment is possible on the recommendation of a doctor.
Before prescribing the drug, the patient must be transferred to a hypocholesterolemic diet, which must be followed throughout the entire period of therapy.
Interaction
Currently, there is no data on the interaction of the drug Atheroklefit® when used together with other drugs, in particular, with lipid-lowering drugs.
Overdose
When using the drug in doses higher than recommended, dose-dependent side effects and signs of alcohol intoxication (dizziness, nausea, vomiting) may increase.
Storage conditions
At a temperature not higher than 25 ºС.
Shelf life
2 years.
Manufacturer
Evalar CJSC, Russia
Shelf life | 2 years. |
---|---|
Conditions of storage | At a temperature not exceeding 25 ºC. |
Manufacturer | Evalar, Russia |
Medication form | oral drops |
Brand | Evalar |
Other forms…
Related products
Buy Atheroklefit, drops, 100 ml with delivery to USA, UK, Europe and over 120 other countries.